My father was diagnosed with stage 4 NSCLC in August.
He tested for EGFR and was given the TKI Afatininb to go on.
In January, the scans weren't showing anything and he was told to celebrate.
Everywhere I read, it's more than likely that Afatinib will stop working.
We will do whatever to increase his odds of staying NED.
We're thinking of using Vaxira or something else in conjunction with Afatinib.
If TKI and immunotherapy function differently, then wouldn't it make sense to use together.
Are there any studies that show taking a more aggressive approach can stop the cancer from coming back?